In this study, the increased expression of ptpn6 was found to be significantly associated with poor prognosis and high immune infiltration in LGG, KIRC, UCS, and TGCT, suggesting its cancer-promoting role in some specific tumor types, as we have described previously. Here, PTPN6 is linked to neoplasm.